Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Pediatric Neurology|June 28, 2017
Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus SyndromeMichael R Pranzatelli, Elizabeth D TateBrain & Development|January 21, 2016
Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndromeMichael R Pranzatelli, Elizabeth D TateChild Neurology Open|October 6, 2018
Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 MalignanciesGuillermo Philipps, Elizabeth D Tate, Michael R PranzatelliJournal of Neuroimmunology|April 25, 2018
Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMSMichael R Pranzatelli, Nathan R McGee, Elizabeth D TateCytokine|March 14, 2017
Case-control, exploratory study of cerebrospinal fluid chemokines/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markersMichael R Pranzatelli, Elizabeth D Tate, Tyler J AllisonPediatric Blood & Cancer|May 5, 2018
Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US childrenMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGeeFrontiers in Neurology|September 30, 2017
Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional StudyMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGeeEuropean Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 21, 2018
Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot studyMichael R Pranzatelli, Tyler J Allison, Elizabeth D TateJournal of the Neurological Sciences|October 10, 2017
Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference rangesMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGeePediatrics|December 17, 2004
Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndromeMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.Pageof 5